STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Pluri CEO awarded 39,050 RSUs; potential 9,266 more by Dec 31, 2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pluri Inc. reported that its Board granted CEO Yaky Yanay equity awards recognizing 2025 performance. The package includes 39,050 fully vested RSUs and stock options for 39,050 shares, exercisable for three years at an exercise price of $5.00 per share. The Board also approved a contingent award of 9,266 RSUs and options for 9,266 shares, with a grant date upon satisfaction of specified objectives by December 31, 2025, and the options exercisable for three years at $5.00.

Positive

  • None.

Negative

  • None.
false 0001158780 0001158780 2025-10-15 2025-10-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): October 16, 2025 (October 15, 2025)

 

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-31392   98-0351734
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

MATAM Advanced Technology Park    
Building No. 5    
Haifa, Israel   3508409
(Address of Principal Executive Offices)   (Zip Code)

 

011 972 74 710 8600

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares, par value $0.00001 per share   PLUR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 15, 2025, the board of directors (the “Board”) of Pluri Inc. approved a grant of equity awards to Yaky Yanay, the Company’s Chief Executive Officer (the “CEO”), in recognition of the achievement of certain performance objectives and other accomplishments during fiscal year 2025. The approved equity awards consist of (i) 39,050 restricted stock units (“RSUs”) which are fully vested, and (ii) stock options to purchase 39,050 common shares of the Company which are fully vested and exercisable for a period of three years at an exercise price of $5.00 per share.

 

The Board further approved, contingent upon the achievement of certain objectives and accomplishments by December 31, 2025, the future grant to the CEO of (i) 9,266 RSUs, and (ii) stock options to purchase 9,266 common shares of the Company. The grant date of such RSUs and stock options, if awarded, will be the date on which the applicable objectives are satisfied, and the stock options will be exercisable for three years at an exercise price of $5.00 per share.

  

1 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLURI INC.
   
Date: October 16, 2025 By: /s/ Liat Zalts
  Name: Liat Zalts
  Title: Chief Financial Officer

  

2 

 

FAQ

What equity awards did PLUR grant its CEO?

The CEO received 39,050 fully vested RSUs and stock options for 39,050 shares at an exercise price of $5.00 per share, exercisable for three years.

Is there a contingent grant for PLUR’s CEO?

Yes. The Board approved a future grant of 9,266 RSUs and options for 9,266 shares, contingent on achieving objectives by December 31, 2025.

What is the exercise term and price of the options?

Both the current and contingent options are exercisable for three years at an exercise price of $5.00 per share.

When will the contingent awards be granted?

Their grant date will be the date on which the applicable objectives are satisfied by December 31, 2025.

Were the granted RSUs vested immediately?

Yes. The 39,050 RSUs granted to the CEO are fully vested.

Why were these awards granted?

They were approved in recognition of the CEO’s achievement of certain performance objectives and other accomplishments during fiscal year 2025.
Pluri Inc

NASDAQ:PLUR

PLUR Rankings

PLUR Latest News

PLUR Latest SEC Filings

PLUR Stock Data

31.09M
6.56M
43.41%
19.65%
0.31%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
HAIFA